Drug Safety
Articles tagged drug safety.
GLP-1 Drugs Beyond Weight Loss: 5 FDA-Approved Uses You Missed
GLP-1 drugs now treat heart disease, kidney failure, and sleep apnea. FDA data shows 5 approved indications beyond diabetes and weight loss for semaglutide, tirzepatide, and liraglutide.
13 min read
Compounded Semaglutide: Safety Risks the FDA Found
FDA tested compounded semaglutide from 38 pharmacies. Potency ranged 62-143% of label. Here's what the inspections revealed and what patients should know.
9 min read
Ozempic vs Mounjaro: Data-Driven Comparison (2026)
Tirzepatide beats semaglutide on weight loss (26.6% vs 15%). But 69,000 FAERS reports tell a more nuanced safety story. Full comparison with trial data and costs.
10 min read
Benadryl Challenge: What FDA Adverse Event Data Shows
We pulled 1,092 FDA FAERS reports for diphenhydramine misuse. The data shows a 2,314% spike in reports during TikTok viral periods, 310 deaths, and a resurgence in 2025-2026.
9 min read
Ozempic Side Effects: What 69,000 FDA Reports Actually Show
We analyzed 69,000 semaglutide adverse event reports in FAERS. Nausea tops at 18%, pancreatitis at 3%. Here's what the data means and what it doesn't.
11 min read
Drug Interaction Data: Where to Find It and How to Use It
A guide to programmatic drug interaction data sources: DailyMed SPL, RxNorm, openFDA labels, and DrugBank. How to build interaction checks into your app.
5 min read